SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001567619-22-012701
Filing Date
2022-06-10
Accepted
2022-06-10 18:33:24
Documents
1
Period of Report
2022-06-08

Document Format Files

Seq Description Document Type Size
1 FORM 4 doc1.html 4  
1 FORM 4 doc1.xml 4 6247
  Complete submission text file 0001567619-22-012701.txt   7552
Mailing Address 5320 LEGACY DRIVE PLANO TX 75024
Business Address 5320 LEGACY DRIVE PLANO TX 75024 972-865-2219
REATA PHARMACEUTICALS INC (Issuer) CIK: 0001358762 (see all company filings)

IRS No.: 113651945 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address 500 CRESCENT COURT SUITE 250 DALLAS TX 75201
Business Address
McGaughy R Kent Jr (Reporting) CIK: 0001402856 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-37785 | Film No.: 221010255